Explore how generic drug patents and exclusivity periods differ across the US, EU, and other regions. Understand the impact of Hatch-Waxman, data exclusivity, and patent extensions on medication costs.
Read More >>
Discover how first generic approval works under the Hatch-Waxman Act. Learn about the 180-day exclusivity, Paragraph IV certifications, and why this process saves patients billions in drug costs.
Read More >>
Effective patent life for drugs is often just 10-15 years, not the full 20, because most of the patent term is used up during clinical trials and FDA review. Secondary patents and regulatory exclusivities extend this further, delaying generic competition.
Read More >>